Proveca Pharma Limited
4 products tracked · names used in filings: Proveca Pharma Limited
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Thu 23 Jul 2026🇪🇺 CHMP negative opinion
KemSu (sufentanil;ketamine): CHMP negative opinion
Fri 29 May 2026🇪🇺 EU approval (EC decision)
Bopediat (furosemide) approved in the EU
Marketing authorisation to Proveca Pharma Limited · source
Thu 26 Mar 2026🇪🇺 CHMP positive opinion
Bopediat (furosemide): CHMP positive opinion
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | KemSu sufentanil;ketamine | Refused | |
| 🇪🇺 | Bopediat furosemide | Authorised | 2026-05-29 |
| 🇪🇺 | Aqumeldi enalapril maleate | Authorised | 2023-11-15 |
| 🇪🇺 | Sialanar glycopyrronium bromide | Authorised | 2016-09-15 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.